BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Diagnosis
11 results:

  • 1. Primary ewing sarcoma in the uterine cervix with multiple bone metastases.
    Jia P; Cui R; Zhang Y
    Arch Gynecol Obstet; 2022 Sep; 306(3):911-912. PubMed ID: 35665855
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. P1 promoter IGF-1 polymorphism and IGF-1, IGF-R, LSF, and TSG 101 expression profile in endometriosis.
    Kwasniewski W; Stupak A; Wolun-Cholewa M; Fronczek A; Kwasniewska A; Kotarski J; Polak G; Gozdzicka-Jozefiak A
    Ginekol Pol; 2022; 93(10):775-786. PubMed ID: 35072229
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [A Case of Sigmoid Colon cancer with Metastasis to the Uterus].
    Tokoro Y; Tonooka T; Souda H; Takiguchi N; Chibana T; Kobayashi R; Arimitsu H; Yanagibashi H; Chou A; Ikeda A; Nabeya N; Kainuma O; Yamamoto H; Nagata M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1662-4. PubMed ID: 26805130
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cervical cytological screening: Assessment of the Fournier ® self-sampling device in a cervical pathology outpatient clinic.
    da Silva Rocha A; Guilherme Schaefer P; Isabel Albano Edelweiss M
    Diagn Cytopathol; 2015 Oct; 43(10):802-9. PubMed ID: 26223029
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Forkhead box protein P1 is a useful marker for the diagnosis of mucinous minimal deviation adenocarcinoma of uterine cervix.
    Yang Q; Jiang W; Li L; Huang Q; Yang KX
    Ann Diagn Pathol; 2014 Aug; 18(4):232-7. PubMed ID: 24908370
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Complete hydatidiform mole coexisting with a normal fetus delivered at 33 weeks of gestation and involving maternal lung metastasis: a case report.
    Sasaki Y; Ogawa K; Takahashi J; Okai T
    J Reprod Med; 2012; 57(7-8):301-4. PubMed ID: 22838245
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of the IGF-I promoter P1 polymorphism with risk of cervical cancer.
    Pacholska-Bogalska J; Józefiak A; Nowak W; Kedzia W; Kwaśniewska A; Goździcka-Józefiak A
    Eur J Gynaecol Oncol; 2011; 32(4):393-8. PubMed ID: 21941959
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.
    Jacob F; Goldstein DR; Bovin NV; Pochechueva T; Spengler M; Caduff R; Fink D; Vuskovic MI; Huflejt ME; Heinzelmann-Schwarz V
    Int J Cancer; 2012 Jan; 130(1):138-46. PubMed ID: 21351089
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Antibody anti-p16(INK4a) in cervical cytology.
    Rocha AS; Bozzetti MC; Kirschnick LS; Edelweiss MI
    Acta Cytol; 2009; 53(3):253-62. PubMed ID: 19534263
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma.
    Torng PL; Lee YC; Huang CY; Ye JH; Lin YS; Chu YW; Huang SC; Cohen P; Wu CW; Lin CT
    Oncogene; 2008 Apr; 27(15):2137-47. PubMed ID: 17952116
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Increased laminin-1 expression in hydatidiform mole.
    Iwahashi M; Muragaki Y; Ooshima A; Nakano R
    Mol Hum Reprod; 1997 Dec; 3(12):1107-11. PubMed ID: 9464856
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.